Provided by Tiger Trade Technology Pte. Ltd.

Vertex Pharmaceuticals

512.04
+3.700.73%
Volume:356.07K
Turnover:181.29M
Market Cap:129.91B
PE:29.80
High:513.98
Open:506.92
Low:501.01
Close:508.34
52wk High:560.25
52wk Low:374.17
Shares:253.72M
Float Shares:253.72M
Volume Ratio:0.51
T/O Rate:0.14%
Dividend:- -
Dividend Rate:- -
EPS(TTM):17.18
EPS(LYR):15.32
ROE:23.54%
ROA:11.93%
PB:6.42
PE(LYR):33.42

Loading ...

Vertex Pharmaceuticals Incorporated : Leerink Partners Resumes Coverage with Outperform Rating; Target Price $594

THOMSON REUTERS
·
Yesterday

Correction to Vertex Material Listing Article on Sept. 17

Dow Jones
·
Yesterday

Vertex Pharmaceuticals Inc. Stock Underperforms Friday When Compared to Competitors

Dow Jones
·
Sep 19

Vertex wins approval for 24/7 underground operations at Reward Gold Mine

TIPRANKS
·
Sep 18

Vortex Energy Moves to Acquire Saskatchewan Meadows Project for Future Energy Storage Potential

TIPRANKS
·
Sep 18

Malaysia's Vertex Material Sets Sights on 2027 U.S. Listing

Dow Jones
·
Sep 17

Analysts Offer Insights on Healthcare Companies: Vertex Pharmaceuticals (VRTX), Ascendis Pharma (ASND) and Charles River Labs (CRL)

TIPRANKS
·
Sep 16

Vertex Pharmaceuticals partners with Lindsey Vonn for JOURNAVX awareness

TIPRANKS
·
Sep 15

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Centene (CNC), Natera (NTRA) and Vertex Pharmaceuticals (VRTX)

TIPRANKS
·
Sep 15

Vertex Minerals Revises Timeline for Proposed Securities Issue

TIPRANKS
·
Sep 14

Vertex Pharmaceuticals Price Target Raised to $560.00/Share from $515.00 by JP Morgan

Dow Jones
·
Sep 11

Vertex Minerals Confirms Reward Gold Mine Resource After ASX‑Driven Update

TIPRANKS
·
Sep 11

Vertex Pharmaceuticals Inc. Stock Underperforms Thursday When Compared to Competitors

Dow Jones
·
Sep 11

Vertex Pharma EVP Jasper Van Grunsven Files Initial Beneficial Ownership Statement

Reuters
·
Sep 11

Vertex Pharmaceuticals Inc. Stock Underperforms Tuesday When Compared to Competitors

Dow Jones
·
Sep 09

Vertex Pharmaceuticals Inc Stock (VRTX) Moved Down by 3.06% on Sep 8: What Signal Does It Send?

TradingKey
·
Sep 09

Movement Alert|Vertex Pharmaceuticals Falls 3.1% in Regular Trading, Trading at $527.91

Market Focus
·
Sep 08

Aclaris, EyePoint, Vertex, GitLab, NioCorp Trending With Analysts

TIPRANKS
·
Sep 05

Vertex Pharmaceuticals Inc. Stock Underperforms Friday When Compared to Competitors

Dow Jones
·
Sep 05

Vortex Energy to Launch Ground Gravity Survey at Robinsons River Salt Project

TIPRANKS
·
Sep 04